bRIGHT 2-year real-world outcomes, presented by R. Bekeredjian
bRIGHT results support the exceptional safety and effectiveness of TriClip TEER in real-world population at 2 years
LEARN MORE:
Related Resources
Valvular Heart Disease Guidelines at a Glance
Demonstrated Outcomes. Life-Changing Intervention
Reduced HF Hospitalisation. Improved Quality of Life
Immediate Relief. Durable Benefits
Tri.Fr 2 years outcomes
Navitor 5-years data from CRT
Tendyne expanded clinical study | PCR LV 2025
EXPAND G4 clinical data release | PCR LV 2025